Neoadjuvant chemotherapy for breast cancer—background for the indication of locoregional treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology, Nuclear Medicine and imaging
Link
http://link.springer.com/article/10.1007/s00066-018-1329-8/fulltext.html
Reference41 articles.
1. Wenz F, Budach W (2017) Personalized radiotherapy for invasive breast cancer in 2017: National S3 guidelines and DEGRO and AGO recommendations. Strahlenther Onkol 193:601–603. https://doi.org/10.1007/s00066-017-1158-1
2. Krug D, Baumann R, Budach W et al (2018) Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer: a systematic review. Strahlenther Onkol 194:607–618. https://doi.org/10.1007/s00066-018-1270-x
3. Kaufmann M, von Minckwitz G, Mamounas EP et al (2011) Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol 19:1508–1516. https://doi.org/10.1245/s10434-011-2108-2
4. Liedtke C, Thill M, on behalf of the AGO Breast Committee (2016) AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2016. Breast Care 11:204–214. https://doi.org/10.1159/000446941
5. Groheux D, Moretti J‑L, Baillet G et al (2008) Effect of (18)F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer. Int J Radiat Oncol Biol Phys 71:695–704. https://doi.org/10.1016/j.ijrobp.2008.02.056
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Strahlentherapie des Mammakarzinoms – wann wieviel?;Die Gynäkologie;2024-04-04
2. Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy;The Breast;2024-04
3. Strahlentherapeutische Konzepte nach Neoadjuvanz;Die Gynäkologie;2023-04-27
4. PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer;Frontiers in Oncology;2022-11-07
5. Post-Neoadjuvant Treatment Strategies in Breast Cancer;Cancers;2022-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3